Atreca – Turning the Current Cancer Therapeutic Discovery Paradigm on its Head
John Orwin, President and CEO of Atreca, a biopharmaceutical company, discusses their drug Discovery Platform and how they are thinking differently abou...
5240 articles
John Orwin, President and CEO of Atreca, a biopharmaceutical company, discusses their drug Discovery Platform and how they are thinking differently abou...
Colon cancer is the second deadliest cancer impacting both men and women, but it’s considered preventable if caught in earlier stages when it is most...
Patricia Whitley-Williams, President of the National Foundation for Infectious Diseases (NFID) discusses the persistent gaps and racial disparities in v...
Rebecca Seidel, President of the Cardiac Ablation Solutions Operating Unit at Medtronic, discusses the FDA approval of the DiamondTemp™ Ablation (DTA)...
Timothy Henry, MD, Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The...
Garrett Bain, President of EcoGen BioSciences in Grand Junction, Colorado, discusses the increased demand for CBD therapeutics. He talks about the dif...
Scott Megaffin, CEO of Adastra Pharmaceuticals, Inc., a company focused on the treatment of cancers with high unmet needs (such as high-grade gliomas), ...
Astellas Oncology has announced the three finalists for the 2020 C3 Prize (Changing Cancer Care). One of the finalists, Lisa McKenzie is here to share...
at ViiV Healthcare, discusses a recent report released by ViiV Healthcare called “Tal Como Soy/Here as I Am” which analyzed multiple factors that co...
Returning guest and study author, Steve Shak, Chief Medical Officer at Exact Sciences discusses results presented at SABCS (San Antonio Breast Cancer Sy...